These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34345229)

  • 1. The association between epicardial adipose tissue and non-alcoholic fatty liver disease: A systematic review of existing human studies.
    Emamat H; Tangestani H; Behrad Nasab M; Ghalandari H; Hekmatdoost A
    EXCLI J; 2021; 20():1096-1105. PubMed ID: 34345229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of epicardial adipose tissue with non-alcoholic fatty liver disease: a meta-analysis.
    Liu B; Li Y; Li Y; Liu Y; Yan Y; Luo A; Ren H; She Q
    Hepatol Int; 2019 Nov; 13(6):757-765. PubMed ID: 31432447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of pomegranate (Punica granatum) on nonalcoholic fatty liver disease: A systematic review of in vivo interventional studies.
    Tangestani H; Jamshidi A; Farhadi A; Ghalandari H; Dehghani P; Moghaddas N; Safaei Z; Emamat H
    Phytother Res; 2024 Jun; ():. PubMed ID: 38923154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased severity of liver fat content and liver fibrosis in non-alcoholic fatty liver disease correlate with epicardial fat volume in type 2 diabetes: A prospective study.
    Brouha SS; Nguyen P; Bettencourt R; Sirlin CB; Loomba R
    Eur Radiol; 2018 Apr; 28(4):1345-1355. PubMed ID: 29058029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epicardial Fat in Nonalcoholic Fatty Liver Disease: Properties and Relationships With Metabolic Factors, Cardiac Structure, and Cardiac Function.
    Psychari SN; Rekleiti N; Papaioannou N; Varhalama E; Drakoulis C; Apostolou TS; Iliodromitis EK
    Angiology; 2016 Jan; 67(1):41-8. PubMed ID: 25818101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of epicardial fat volume and nonalcoholic fatty liver disease with metabolic syndrome: From the CAESAR study.
    Kim BJ; Kim HS; Kang JG; Kim BS; Kang JH
    J Clin Lipidol; 2016; 10(6):1423-1430.e1. PubMed ID: 27919360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epicardial adipose tissue volume is associated with non-alcoholic fatty liver disease and cardiovascular risk factors in the general population.
    Meng X; Wang W; Zhang K; Qi Y; An S; Wang S; Zheng J; Kong J; Liu H; Wu J; Zhou Y; Gao C; Tang YD
    Ther Clin Risk Manag; 2018; 14():1499-1506. PubMed ID: 30197519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of epicardial fat thickness and nonalcoholic fatty liver disease to coronary artery calcification: From the CAESAR study.
    Kim BJ; Cheong ES; Kang JG; Kim BS; Kang JH
    J Clin Lipidol; 2016; 10(3):619-626.e1. PubMed ID: 27206950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epicardial fat, cardiac geometry and cardiac function in patients with non-alcoholic fatty liver disease: association with the severity of liver disease.
    Petta S; Argano C; Colomba D; Cammà C; Di Marco V; Cabibi D; Tuttolomondo A; Marchesini G; Pinto A; Licata G; Craxì A
    J Hepatol; 2015 Apr; 62(4):928-33. PubMed ID: 25445395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epicardial Adipose Tissue (EAT) Thickness Is Associated with Cardiovascular and Liver Damage in Nonalcoholic Fatty Liver Disease.
    Fracanzani AL; Pisano G; Consonni D; Tiraboschi S; Baragetti A; Bertelli C; Norata GD; Dongiovanni P; Valenti L; Grigore L; Tonella T; Catapano A; Fargion S
    PLoS One; 2016; 11(9):e0162473. PubMed ID: 27627804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between non-alcoholic fatty liver disease and obstructive sleep apnea.
    Umbro I; Fabiani V; Fabiani M; Angelico F; Del Ben M
    World J Gastroenterol; 2020 May; 26(20):2669-2681. PubMed ID: 32523319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lifestyle predictors of obese and non-obese patients with nonalcoholic fatty liver disease: A cross-sectional study.
    Kwak JH; Jun DW; Lee SM; Cho YK; Lee KN; Lee HL; Lee OY; Choi HS; Yoon BC
    Clin Nutr; 2018 Oct; 37(5):1550-1557. PubMed ID: 28918170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind, placebo-controlled randomized trial to evaluate the efficacy of docosahexaenoic acid supplementation on hepatic fat and associated cardiovascular risk factors in overweight children with nonalcoholic fatty liver disease.
    Pacifico L; Bonci E; Di Martino M; Versacci P; Andreoli G; Silvestri LM; Chiesa C
    Nutr Metab Cardiovasc Dis; 2015 Aug; 25(8):734-41. PubMed ID: 26026214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epicardial fat thickness and nonalcoholic fatty liver disease in obese subjects.
    Iacobellis G; Barbarini G; Letizia C; Barbaro G
    Obesity (Silver Spring); 2014 Feb; 22(2):332-6. PubMed ID: 24115757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between Diet and Non-alcoholic Fatty Liver Disease: A Review Article.
    Mirmiran P; Amirhamidi Z; Ejtahed HS; Bahadoran Z; Azizi F
    Iran J Public Health; 2017 Aug; 46(8):1007-1017. PubMed ID: 28894701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between nonalcoholic fatty liver disease and cardiovascular risk in obese children and adolescents.
    Alp H; Karaarslan S; Selver Eklioğlu B; Atabek ME; Altın H; Baysal T
    Can J Cardiol; 2013 Sep; 29(9):1118-25. PubMed ID: 23040432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review article: coffee consumption, the metabolic syndrome and non-alcoholic fatty liver disease.
    Yesil A; Yilmaz Y
    Aliment Pharmacol Ther; 2013 Nov; 38(9):1038-44. PubMed ID: 24024834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults.
    Vernon G; Baranova A; Younossi ZM
    Aliment Pharmacol Ther; 2011 Aug; 34(3):274-85. PubMed ID: 21623852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved body composition decreases the fat content in non-alcoholic fatty liver disease, a meta-analysis and systematic review of longitudinal studies.
    Mátis D; Hegyi P; Teutsch B; Tornai T; Erőss B; Pár G; Váncsa S
    Front Med (Lausanne); 2023; 10():1114836. PubMed ID: 37215704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis.
    Ye Q; Zou B; Yeo YH; Li J; Huang DQ; Wu Y; Yang H; Liu C; Kam LY; Tan XXE; Chien N; Trinh S; Henry L; Stave CD; Hosaka T; Cheung RC; Nguyen MH
    Lancet Gastroenterol Hepatol; 2020 Aug; 5(8):739-752. PubMed ID: 32413340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.